Atea Pharmaceuticals director Bruce Polsky sells 8,750 shares, reflecting strategic financial management within the pharmaceutical preparations industry.
| Name | Atea Pharmaceuticals, Inc. |
|---|---|
| CIK | 0001593899 |
| Tickers | AVIR |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 460574869 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | MA MA |
| Phone | (857) 284-8891 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Atea Pharmaceuticals director Bruce Polsky sells 8,750 shares, reflecting strategic financial management within the pharmaceutical preparations industry.
Bruce Polsky, a director at Atea Pharmaceuticals, reported significant stock transactions, reflecting ongoing management engagement in financial strategies.
Atea Pharmaceuticals reveals updated beneficial ownership in SEC filing, indicating significant stakes by JPM Partners LLC and Jean-Pierre Sommadossi.
Atea Pharmaceuticals, Inc. releases quarterly results, showcasing its commitment to innovation in the pharmaceutical preparations sector.
Atea Pharmaceuticals announces positive Q3 2026 results and secures $200 million funding, enhancing its position in the pharmaceutical preparations industry.
Atea Pharmaceuticals has entered a $200 million loan agreement to support its clinical trials and operations, crucial for its drug development.
326 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 4 | 4 | 0001193125-26-469038 | 13850 | ||||||
| 2026-11-19 | 4 | 4 | 0001193125-26-469037 | 5150 | ||||||
| 2026-11-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011363 | 001-39661 | 261575466 | 33 | 5367 | |||
| 2026-11-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011348 | 001-39661 | 261575168 | 33 | 6775 | |||
| 2026-11-18 | 4 | 4 | 0001193125-26-467490 | 19074 | ||||||
| 2026-11-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011332 | 001-39661 | 261571391 | 33 | 6082 | |||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011253 | 001-39661 | 261566813 | 33 | 5381 | |||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011221 | 001-39661 | 261566427 | 33 | 4666 | |||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011130 | 001-39661 | 261560975 | 33 | 4683 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-460848 | 005-91836 | 261553493 | 34 | 9098 | |||
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-453807 | 001-39661 | 261536858 | 34 | 9807494 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-453636 | 001-39661 | 261536208 | 34 | 223541 | 1 | 1 |
| 2026-11-09 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-26-452659 | 001-39661 | 261533817 | 34 | 746604 | 1 | 1 |
| 2026-10-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-012604 | 005-91836 | 261445088 | 34 | 27348 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-347021 | 001-39661 | 261268263 | 34 | 9153477 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-346888 | 001-39661 | 261267680 | 34 | 226137 | 1 | 1 |
| 2026-06-23 | 4 | 4 | 0001193125-26-279728 | 11468 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279726 | 11484 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279723 | 7945 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279721 | 11600 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279719 | 11483 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279718 | 11477 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279720 | 11491 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279717 | 8043 | ||||||
| 2026-06-22 | 8-K | 8-K | 5.07 | 0001193125-26-277639 | 001-39661 | 261107844 | 34 | 147770 | 1 | 1 |
| 2026-05-21 | 4/A | 4/A | 0001193125-26-235039 | 5469 | ||||||
| 2026-05-20 | 4 | 4 | 0001193125-26-232612 | 5057 | ||||||
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219678 | 001-39661 | 26969436 | 34 | 8123621 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-219507 | 001-39661 | 26968836 | 34 | 208545 | 1 | 1 |
| 2026-05-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001112 | 005-91836 | 26946575 | 34 | 11338 | |||
| 2026-04-27 | DEFA14A | DEFA14A | 0001193125-26-182340 | 001-39661 | 26901832 | 34 | 1909369 | |||
| 2026-04-27 | DEF 14A | DEF 14A | 0001193125-26-182293 | 001-39661 | 26901701 | 34 | 15543241 | 1 | 1 | |
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000786 | 005-91836 | 26798349 | 34 | 7119 | |||
| 2026-03-13 | 4 | 4 | 0001193125-26-106547 | 6614 | ||||||
| 2026-03-05 | 10-K | 10-K | 0001193125-26-094159 | 001-39661 | 26727010 | 34 | 16635234 | 1 | 1 | |
| 2026-03-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-093961 | 001-39661 | 26726215 | 34 | 224641 | 1 | 1 |
| 2026-02-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001373604-26-000010 | 005-91836 | 26610869 | 34 | 7944 | |||
| 2026-02-03 | 4 | 4 | 0001193125-26-036281 | 12674 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-036272 | 13409 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-036270 | 12862 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-036269 | 12902 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-036268 | 14888 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-036261 | 12660 | ||||||
| 2026-01-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-007081 | 001-39661 | 26517656 | 34 | 183426 | 1 | 1 |
| 2025-12-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002957 | 005-91836 | 251552354 | 34 | 11622 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277815 | 001-39661 | 251473742 | 34 | 9420886 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-277627 | 001-39661 | 251472973 | 34 | 225162 | 1 | 1 |
| 2025-08-07 | S-8 | S-8 | 0001193125-25-175553 | 333-289387 | 251195159 | 33 | 195104 | 1 | 1 | |
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105123 | 001-39661 | 251194773 | 34 | 9084969 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-175433 | 001-39661 | 251194098 | 34 | 214376 | 1 | 1 |
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-001974 | 005-91836 | 251188276 | 34 | 11051 | |||
| 2025-06-24 | 4 | 4 | 0000950170-25-089607 | 11401 | ||||||
| 2025-06-24 | 4 | 4 | 0000950170-25-089609 | 11409 | ||||||
| 2025-06-24 | 4 | 4 | 0000950170-25-089606 | 11382 | ||||||
| 2025-06-24 | 4 | 4 | 0000950170-25-089605 | 11375 | ||||||
| 2025-06-24 | 4 | 4 | 0000950170-25-089608 | 11396 | ||||||
| 2025-06-24 | 4 | 4 | 0000950170-25-089604 | 11388 | ||||||
| 2025-06-24 | 4 | 4 | 0000950170-25-089603 | 5223 | ||||||
| 2025-06-24 | 3 | 3 | 0000950170-25-089596 | 17974 | ||||||
| 2025-06-20 | 8-K | 8-K | 5.07 | 0001193125-25-143750 | 001-39661 | 251062309 | 34 | 147657 | 1 | 1 |
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-071707 | 005-91836 | 25947589 | 34 | 8959 | |||
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-069367 | 001-39661 | 25935598 | 34 | 8774379 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-117809 | 001-39661 | 25935201 | 34 | 215575 | 1 | 1 |
| 2025-04-29 | DEF 14A | DEF 14A | 0001193125-25-104019 | 001-39661 | 25888978 | 34 | 8886053 | 1 | 1 | |
| 2025-04-23 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-001472 | 005-91836 | 25863202 | 34 | 10854 | |||
| 2025-04-17 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-001112 | 005-91836 | 25845935 | 34 | 59391 | 1 | 1 | |
| 2025-04-17 | 8-K | 8-K | 1.01,2.02,5.02,7.01,9.01 | 0001193125-25-083523 | 001-39661 | 25844351 | 34 | 299763 | 1 | 1 |
| 2025-04-03 | DEFA14A | DEFA14A | 0001193125-25-072426 | 001-39661 | 25810391 | 34 | 23044 | |||
| 2025-04-01 | DEFA14A | DEFA14A | 0001193125-25-069935 | 001-39661 | 25796955 | 34 | 27021 | |||
| 2025-04-01 | 8-K | 8-K | 8.01 | 0001193125-25-069932 | 001-39661 | 25796952 | 34 | 158021 | 1 | 1 |
| 2025-03-26 | DEFA14A | DEFA14A | 0001193125-25-064180 | 001-39661 | 25774298 | 34 | 27231 | |||
| 2025-03-26 | DFAN14A | dfan14a09076068_03262025.htm | 0000921895-25-000883 | 001-39661 | 25772281 | 34 | 38218 | |||
| 2025-03-24 | DEFA14A | DEFA14A | 0001193125-25-060808 | 001-39661 | 25762157 | 34 | 36372 | |||
| 2025-03-24 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-060794 | 001-39661 | 25762143 | 34 | 171685 | 1 | 1 |
| 2025-03-21 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-000843 | 005-91836 | 25759653 | 34 | 98803 | 1 | 1 | |
| 2025-03-06 | 10-K | 10-K | 0000950170-25-034808 | 001-39661 | 25715954 | 34 | 14616497 | 1 | 1 | |
| 2025-03-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-048426 | 001-39661 | 25715455 | 34 | 217851 | 1 | 1 |
| 2025-03-04 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-000684 | 005-91836 | 25701815 | 34 | 105625 | 1 | 1 | |
| 2025-02-24 | 4 | 4 | 0000950170-25-025901 | 5257 | ||||||
| 2025-02-24 | 3 | 3 | 0000950170-25-025892 | 20200 | ||||||
| 2025-02-24 | 8-K | 8-K | 5.02 | 0001193125-25-032826 | 001-39661 | 25654312 | 34 | 145811 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000162 | 005-91836 | 25625877 | 34 | 15882 | |||
| 2025-02-04 | 4 | 4 | 0000950170-25-013853 | 14528 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013852 | 15075 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013850 | 14339 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013849 | 14609 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013846 | 15048 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013844 | 14306 | ||||||
| 2025-01-17 | 4/A | 4/A | 0000950170-25-006589 | 7329 | ||||||
| 2025-01-17 | 4 | 4 | 0000950170-25-006489 | 6817 | ||||||
| 2025-01-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-005424 | 001-39661 | 25527365 | 34 | 178623 | 1 | 1 |
| 2024-12-16 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-24-000114 | 005-91836 | 241550366 | 34 | 15145 | |||
| 2024-12-12 | 4 | 4 | 0000950170-24-135930 | 4919 | ||||||
| 2024-12-10 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-001157 | 001-39661 | 241539414 | 33 | 5900 | |||
| 2024-11-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-11-19 16:00:00 | 9999999995-24-003516 | 333-283073 | 241478077 | 33 | 1765 | ||
| 2024-11-15 | CORRESP | filename1.htm | 0001193125-24-259812 | 6875 | ||||||
| 2024-11-14 | SC 13G/A | avir13ga3.htm | 0000935836-24-000713 | 005-91836 | 241466290 | 34 | 47291 | |||
| 2024-11-14 | UPLOAD | filename1.pdf | 0000000000-24-012648 | 333-283073 | 40155 | |||||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002676 | 005-91836 | 241444460 | 34 | 8059 | |||
| 2024-11-07 | S-3 | FORM S-3 | 0001193125-24-253272 | 333-283073 | 241436856 | 33 | 654276 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123447 | 001-39661 | 241436629 | 34 | 7226198 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-253143 | 001-39661 | 241436262 | 34 | 215002 | 1 | 1 |
| 2024-09-19 | 4 | 4 | 0000950170-24-108233 | 9858 | ||||||
| 2024-09-19 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000465 | 001-39661 | 241310661 | 33 | 5951 | |||
| 2024-09-18 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000462 | 001-39661 | 241307544 | 33 | 5322 | |||
| 2024-09-17 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000460 | 001-39661 | 241304619 | 33 | 4690 | |||
| 2024-08-07 | 10-Q | 10-Q | 0000950170-24-092914 | 001-39661 | 241184534 | 34 | 7206120 | 1 | 1 | |
| 2024-08-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-195895 | 001-39661 | 241183993 | 34 | 220248 | 1 | 1 |
| 2024-06-21 | 4 | 4 | 0000950170-24-076400 | 7866 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076394 | 7826 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076388 | 7841 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076381 | 7832 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076379 | 9574 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076363 | 7841 | ||||||
| 2024-06-21 | 8-K | 8-K | 5.07 | 0001193125-24-165886 | 001-39661 | 241061423 | 34 | 153511 | 1 | 1 |
| 2024-06-20 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-000924 | 001-39661 | 241057608 | 33 | 4244 | |||
| 2024-06-18 | 4 | 4 | 0000950170-24-074989 | 6760 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074988 | 6750 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074987 | 6745 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074986 | 6747 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074985 | 6784 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074984 | 6759 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070965 | 5117 | ||||||
| 2024-06-05 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000291 | 001-39661 | 241021950 | 33 | 4686 | |||
| 2024-06-04 | DEFA14A | DEFA14A | 0000950170-24-068683 | 001-39661 | 241018202 | 34 | 75970 | |||
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059699 | 001-39661 | 24945203 | 34 | 6557368 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-138249 | 001-39661 | 24944581 | 34 | 209504 | 1 | 1 |
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-049220 | 001-39661 | 24884418 | 34 | 1167501 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-049178 | 001-39661 | 24884121 | 34 | 5786872 | 1 | 1 | |
| 2024-02-28 | 10-K | 10-K | 0000950170-24-022226 | 001-39661 | 24696550 | 34 | 12780308 | 1 | 1 | |
| 2024-02-28 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-050724 | 001-39661 | 24695682 | 34 | 220548 | 1 | 1 |
| 2024-02-14 | SC 13G/A | avir13ga.htm | 0000935836-24-000226 | 005-91836 | 24642814 | 34 | 47288 | |||
| 2024-02-14 | SC 13G/A | avir13ga.htm | 0000935836-24-000207 | 005-91836 | 24642393 | 34 | 47288 | |||
| 2024-02-14 | SC 13G/A | avir13ga.htm | 0000935836-24-000228 | 005-91836 | 24641587 | 34 | 45903 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020352 | 005-91836 | 24627412 | 34 | 13051 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-033799 | 005-91836 | 24626502 | 34 | 58415 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-000968 | 005-91836 | 24611337 | 34 | 8086 | |||
| 2024-02-07 | SC 13G/A | avir13g.htm | 0001616824-24-000017 | 005-91836 | 24602422 | 34 | 83456 | |||
| 2024-02-07 | SC 13G | avir13g.htm | 0001616824-24-000015 | 005-91836 | 24602396 | 34 | 83448 | |||
| 2024-02-02 | 4 | 4 | 0000950170-24-010973 | 10941 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010972 | 11435 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010970 | 10734 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010969 | 10701 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010968 | 11470 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010967 | 10922 | ||||||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009804 | 001-39661 | 24587106 | 33 | 4358 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009803 | 001-39661 | 24587105 | 33 | 4389 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009802 | 001-39661 | 24587104 | 33 | 4386 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009801 | 001-39661 | 24587102 | 33 | 4376 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009800 | 001-39661 | 24587101 | 33 | 4391 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009799 | 001-39661 | 24587100 | 33 | 4367 | |||
| 2024-01-24 | SC 13G/A | us04683r1068_012324.txt | 0001086364-24-002027 | 005-91836 | 24554588 | 34 | 13510 | |||
| 2023-11-28 | SC 13D/A | AMENDMENT NO. 1 | 0001214659-23-015585 | 005-91836 | 231441769 | 34 | 92800 | |||
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-061213 | 001-39661 | 231388640 | 34 | 8022786 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-273532 | 001-39661 | 231388081 | 34 | 216844 | 1 | 1 |
| 2023-11-07 | SC 13G/A | us04683r1068_110623.txt | 0001306550-23-010280 | 005-91836 | 231383348 | 34 | 13419 | |||
| 2023-10-02 | SC 13G | avir13g.htm | 0001616824-23-000007 | 005-91836 | 231298475 | 34 | 60254 | |||
| 2023-09-11 | SC 13G/A | filing.txt | 0000315066-23-002589 | 005-91836 | 231246754 | 34 | 7978 | |||
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039920 | 001-39661 | 231152176 | 34 | 8945143 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-206247 | 001-39661 | 231151697 | 34 | 220597 | 1 | 1 |
| 2023-06-21 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-23-171257 | 001-39661 | 231030687 | 34 | 693037 | 1 | 1 |
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-016129 | 8179 | ||||||
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-016128 | 8167 | ||||||
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-016131 | 8164 | ||||||
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-016126 | 8170 | ||||||
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-016130 | 8179 | ||||||
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-016127 | 8204 | ||||||
| 2023-06-12 | DEFA14A | DEFA14A | 0000950170-23-027367 | 001-39661 | 231007156 | 34 | 104307 | |||
| 2023-05-25 | DEFA14A | DEFA14A | 0000950170-23-024297 | 001-39661 | 23962060 | 34 | 103380 | |||
| 2023-05-22 | SC 13D | z519230sc13d.htm | 0001214659-23-007616 | 005-91836 | 23942601 | 34 | 124062 | |||
| 2023-05-08 | 10-Q | 10-Q | 0000950170-23-018869 | 001-39661 | 23898381 | 34 | 7973801 | 1 | 1 | |
| 2023-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-138257 | 001-39661 | 23897966 | 34 | 205658 | 1 | 1 |
| 2023-04-28 | ARS | ARS | 0000950170-23-015921 | 001-39661 | 23867653 | 34 | 1933349 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0000950170-23-015810 | 001-39661 | 23866280 | 34 | 1159476 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0000950170-23-015773 | 001-39661 | 23866007 | 34 | 9088751 | 1 | 1 | |
| 2023-02-28 | 10-K | 10-K | 0000950170-23-005186 | 001-39661 | 23686769 | 34 | 15885041 | 1 | 1 | |
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-053843 | 001-39661 | 23685396 | 34 | 224725 | 1 | 1 |
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001193125-23-032602 | 005-91836 | 23612077 | 34 | 58101 | |||
| 2023-02-10 | SC 13G/A | avia13ga.htm | 0000935836-23-000099 | 005-91836 | 23610224 | 34 | 47198 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015377 | 005-91836 | 23602470 | 34 | 12971 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001421 | 005-91836 | 23601272 | 34 | 8177 | |||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-003629 | 7918 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-003621 | 7951 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-003615 | 7947 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-003607 | 7938 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-003604 | 7943 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-003600 | 7936 | ||||||
| 2023-01-24 | SC 13G/A | us04683r1068_012423.txt | 0001306550-23-003083 | 005-91836 | 23547505 | 34 | 13343 | |||
| 2022-11-15 | 4 | FORM 4 SUBMISSION | 0000899243-22-035942 | 6895 | ||||||
| 2022-11-07 | 10-Q | 10-Q | 0000950170-22-022699 | 001-39661 | 221366295 | 34 | 7590678 | 1 | 1 | |
| 2022-11-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-279097 | 001-39661 | 221365662 | 34 | 209194 | 1 | 1 |
| 2022-08-08 | 10-Q | 10-Q | 0000950170-22-015570 | 001-39661 | 221144871 | 34 | 6185654 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-214871 | 001-39661 | 221144466 | 34 | 210205 | 1 | 1 |
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-023505 | 5479 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-023504 | 5439 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-023502 | 5454 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-023501 | 5454 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-023498 | 5445 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-023496 | 5442 | ||||||
| 2022-06-21 | 8-K | 8-K | 5.07 | 0001193125-22-177774 | 001-39661 | 221029047 | 34 | 152042 | 1 | 1 |
| 2022-05-12 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-22-146286,2022-05-12 | 9999999995-22-001427 | 333-261344 | 22920041 | 33 | 1728 | ||
| 2022-05-10 | POS AM | POS AM | 0001193125-22-146286 | 333-261344 | 22909666 | 33 | 70279 | |||
| 2022-05-10 | 10-Q | 10-Q | 0000950170-22-008732 | 001-39661 | 22907447 | 34 | 5120004 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-145634 | 001-39661 | 22907264 | 34 | 237245 | 1 | 1 |
| 2022-04-29 | DEFA14A | DEFA14A | 0001193125-22-134271 | 001-39661 | 22877533 | 34 | 482268 | |||
| 2022-04-29 | DEF 14A | DEF 14A | 0001193125-22-134263 | 001-39661 | 22877477 | 34 | 1899458 | |||
| 2022-03-01 | POS AM | POS AM | 0001193125-22-058650 | 333-261344 | 22692462 | 33 | 437891 | |||
| 2022-02-28 | 10-K | 10-K | 0001564590-22-007672 | 001-39661 | 22691232 | 34 | 17445742 | 1 | 1 | |
| 2022-02-28 | POSASR | POSASR | 0001193125-22-058027 | 333-261344 | 22690333 | 33 | 439022 | |||
| 2022-02-28 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-057911 | 001-39661 | 22689588 | 34 | 222748 | 1 | 1 |
| 2022-02-16 | SC 13G/A | SC 13G/A | 0001104659-22-024235 | 005-91836 | 22643482 | 34 | 73169 | |||
| 2022-02-14 | SC 13G/A | ATEA PHARMACEUTICALS, INC. | 0001104659-22-022762 | 005-91836 | 22631941 | 34 | 82596 | |||
| 2022-02-14 | SC 13G/A | schedule13g.htm | 0000929638-22-000477 | 005-91836 | 22630162 | 34 | 152378 | |||
| 2022-02-10 | SC 13G/A | SC 13G/A | 0001193125-22-034452 | 005-91836 | 22614107 | 34 | 57184 | |||
| 2022-02-09 | SC 13G | SCHEDULE 13G | 0001104659-22-016552 | 005-91836 | 22606479 | 34 | 12930 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-000787 | 005-91836 | 22604091 | 34 | 8796 | |||
| 2022-02-04 | SC 13G | us04683r1068_020422.txt | 0000834237-22-007341 | 005-91836 | 22593615 | 34 | 13328 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004183 | 5381 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004186 | 5400 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004185 | 5421 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004182 | 5420 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004184 | 5346 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004181 | 5407 | ||||||
| 2022-01-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-005119 | 001-39661 | 22519782 | 34 | 13093791 | 1 | 1 |
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-049313 | 5018 | ||||||
| 2021-12-10 | SC 13G | ateapharm13g.htm | 0000935836-21-000685 | 005-91836 | 211486168 | 34 | 45428 | |||
| 2021-11-26 | 8-K | 8-K | 7.01 | 0001193125-21-341283 | 001-39661 | 211452122 | 34 | 143581 | 1 | 1 |
| 2021-11-24 | S-3ASR | S-3ASR | 0001193125-21-340320 | 333-261344 | 211446470 | 33 | 881526 | |||
| 2021-11-16 | 8-K | 8-K | 1.02 | 0001193125-21-331369 | 001-39661 | 211417311 | 34 | 145057 | 1 | 1 |
| 2021-11-12 | 10-Q | 10-Q | 0001564590-21-056513 | 001-39661 | 211399948 | 34 | 5797393 | 1 | 1 | |
| 2021-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-327268 | 001-39661 | 211399450 | 34 | 223899 | 1 | 1 |
| 2021-09-24 | SC 13D/A | SC 13D/A | 0001193125-21-282487 | 005-91836 | 211278229 | 34 | 66899 | |||
| 2021-09-03 | SC 13D/A | SC 13D/A | 0001193125-21-265615 | 005-91836 | 211237246 | 34 | 65820 | |||
| 2021-08-12 | 10-Q | 10-Q | 0001564590-21-044060 | 001-39661 | 211168793 | 34 | 6957707 | 1 | 1 | |
| 2021-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-244683 | 001-39661 | 211167667 | 34 | 96048 | ||
| 2021-07-23 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-21-223025 | 001-39661 | 211111040 | 34 | 86062 | ||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-025049 | 5437 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-025047 | 5440 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-025045 | 5474 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-025044 | 5434 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-025037 | 5449 | ||||||
| 2021-06-21 | 8-K | 8-K | 5.07 | 0001193125-21-195034 | 001-39661 | 211030522 | 34 | 21272 | ||
| 2021-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-020247 | 5277 | ||||||
| 2021-05-20 | 3 | FORM 3 SUBMISSION | 0000899243-21-020241 | 6961 | ||||||
| 2021-05-20 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-167921 | 001-39661 | 21945304 | 34 | 54188 | ||
| 2021-05-20 | DEFA14A | DEFA14A | 0001193125-21-167778 | 001-39661 | 21944584 | 34 | 28585 | |||
| 2021-05-13 | 10-Q | 10-Q | 0001564590-21-027644 | 001-39661 | 21920827 | 34 | 4019161 | 1 | ||
| 2021-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-160492 | 001-39661 | 21919713 | 34 | 67979 | ||
| 2021-04-29 | DEFA14A | DEFA14A | 0001193125-21-140416 | 001-39661 | 21870621 | 34 | 552677 | |||
| 2021-04-29 | DEF 14A | DEF 14A | 0001193125-21-140382 | 001-39661 | 21870516 | 34 | 820146 | |||
| 2021-04-19 | 8-K | 8-K | 5.02 | 0001193125-21-120430 | 001-39661 | 21833303 | 34 | 16695 | ||
| 2021-04-07 | SC 13G/A | SC 13G/A | 0001104659-21-047577 | 005-91836 | 21812487 | 34 | 83461 | |||
| 2021-03-30 | 10-K | 10-K | 0001564590-21-016724 | 001-39661 | 21787961 | 34 | 9796241 | 1 | ||
| 2021-03-10 | SC 13G/A | filing.txt | 0000315066-21-001424 | 005-91836 | 21728492 | 34 | 8446 | |||
| 2021-02-16 | SC 13G | SC 13G | 0001104659-21-024251 | 005-91836 | 21639684 | 34 | 72073 | |||
| 2021-02-16 | SC 13G | SCHEDULE 13G | 0001104659-21-024052 | 005-91836 | 21638800 | 34 | 88248 | |||
| 2021-02-16 | SC 13G/A | schedule13g.htm | 0000929638-21-000379 | 005-91836 | 21637190 | 34 | 152706 | |||
| 2021-02-10 | SC 13G | SC 13G | 0001193125-21-036341 | 005-91836 | 21614340 | 34 | 66277 | |||
| 2021-02-08 | SC 13G | filing.txt | 0000315066-21-000815 | 005-91836 | 21599319 | 34 | 8441 | |||
| 2021-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-003873 | 5356 | ||||||
| 2021-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-003872 | 5352 | ||||||
| 2021-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-003869 | 5347 | ||||||
| 2021-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-003868 | 5345 | ||||||
| 2021-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-003867 | 5360 | ||||||
| 2021-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-003866 | 5357 | ||||||
| 2020-12-10 | 10-Q | 10-Q | 0001564590-20-056724 | 001-39661 | 201380710 | 34 | 6053498 | 1 | ||
| 2020-11-13 | SC 13G | schedule13g.htm | 0000929638-20-001091 | 005-91836 | 201311373 | 34 | 173782 | |||
| 2020-11-12 | SC 13D | SC 13D | 0001193125-20-291677 | 005-91836 | 201306894 | 34 | 124321 | |||
| 2020-11-05 | 8-K | 8-K | 5.03,9.01 | 0001193125-20-286850 | 001-39661 | 201290825 | 34 | 274908 | ||
| 2020-11-05 | 4 | FORM 4 | 0001567619-20-018747 | 26026 | ||||||
| 2020-11-04 | 4 | FORM 4 SUBMISSION | 0000899243-20-030382 | 23813 | ||||||
| 2020-11-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-030340 | 12858 | ||||||
| 2020-11-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-030332 | 9744 | ||||||
| 2020-11-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-030331 | 17231 | ||||||
| 2020-11-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-030330 | 9237 | ||||||
| 2020-11-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-030329 | 7374 | ||||||
| 2020-11-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-030324 | 11355 | ||||||
| 2020-11-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-030323 | 7431 | ||||||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029960 | 5275 | ||||||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029959 | 5238 | ||||||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029956 | 5244 | ||||||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029954 | 5247 | ||||||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029953 | 5290 | ||||||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029951 | 5244 | ||||||
| 2020-10-30 | S-8 | S-8 | 0001193125-20-282778 | 333-249780 | 201278371 | 33 | 132384 | |||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029945 | 5238 | ||||||
| 2020-10-30 | 424B4 | 424B4 | 0001193125-20-282645 | 333-249404 | 201277790 | 33 | 4233529 | |||
| 2020-10-29 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-10-29 16:00:00 | 9999999995-20-003030 | 333-249404 | 201274575 | 33 | 1712 | ||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029797 | 12346 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029796 | 7255 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029795 | 9624 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029793 | 10111 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029794 | 12329 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029781 | 14386 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029779 | 7222 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029778 | 10114 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029777 | 11147 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029776 | 22689 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029775 | 15926 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029774 | 8532 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029773 | 11245 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029772 | 8565 | ||||||
| 2020-10-29 | 3 | FORM 3 SUBMISSION | 0000899243-20-029765 | 6509 | ||||||
| 2020-10-29 | 3 | FORM 3 | 0001567619-20-018348 | 17515 | ||||||
| 2020-10-29 | S-1MEF | S-1MEF | 0001193125-20-281196 | 333-249736 | 201273734 | 33 | 44760 | |||
| 2020-10-29 | CORRESP | filename1.htm | 0001193125-20-280670 | 41089 | ||||||
| 2020-10-28 | CERT | 8A CERT | 0001354457-20-000645 | 001-39661 | 201266455 | 34 | 488137 | |||
| 2020-10-27 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-005162 | 274587 | ||||||
| 2020-10-27 | CORRESP | filename1.htm | 0001193125-20-278377 | 13488 | ||||||
| 2020-10-27 | CORRESP | filename1.htm | 0001193125-20-278374 | 7472 | ||||||
| 2020-10-27 | UPLOAD | filename1.pdf | 0000000000-20-010154 | 42413 | ||||||
| 2020-10-26 | S-1/A | AMENDMENT 2 TO FORM S-1 | 0001193125-20-275997 | 333-249404 | 201258971 | 33 | 5300053 | |||
| 2020-10-26 | 8-A12B | 8-A12B | 0001193125-20-275982 | 001-39661 | 201258957 | 34 | 12646 | |||
| 2020-10-23 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-005123 | 276764 | ||||||
| 2020-10-23 | S-1/A | AMENDMENT 1 TO FORM S-1 | 0001193125-20-274635 | 333-249404 | 201255906 | 33 | 5355937 | |||
| 2020-10-09 | S-1 | S-1 | 0001193125-20-267199 | 333-249404 | 201233224 | 33 | 5892744 | |||
| 2020-08-07 | DRSLTR | filename1.htm | 0000950123-20-007961 | 47448 | ||||||
| 2020-08-07 | DRS/A | filename1.htm | 0000950123-20-007958 | 377-03231 | 201086570 | 33 | 4269022 | |||
| 2020-07-16 | UPLOAD | filename1.pdf | 0000000000-20-006512 | 58271 | ||||||
| 2020-06-19 | DRS | filename1.htm | 0000950123-20-006302 | 377-03231 | 20974093 | 33 | 4896607 | |||
| 2020-05-29 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-011337 | 021-367951 | 20927396 | 33 | 12043 | ||
| 2018-07-16 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-18-032512 | 021-316941 | 18954220 | 33 | 11998 | ||
| 2016-09-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-16-079687 | 021-270551 | 161883297 | 33 | 11090 | ||
| 2014-09-17 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001140361-14-035805 | 021-207797 | 141107035 | 33 | 10696 | ||
| 2014-05-21 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001140361-14-022477 | 021-207797 | 14860767 | 33 | 10593 | ||
| 2013-12-11 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-13-045616 | 021-207797 | 131270503 | 33 | 10509 |
One latest value per concept from companyfacts (234 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 80.30M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 262.60M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.64M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001193125-26-182293 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.57M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001193125-26-182293 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001193125-26-182293 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 3.60M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001193125-26-182293 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 3.40M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001193125-26-182293 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 8.54 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-27 | 0001193125-26-182293 | ||
| srt | StockRepurchaseProgramAuthorizedAmount1 | StockRepurchaseProgramAuthorizedAmount1 | USD | 25.00M | 2025-04-30 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 4.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 4.51M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022699 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 99,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022226 | |
| us-gaap | AccruedIncomeTaxesNoncurrent | Accrued Income Taxes, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 19.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.52M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -73,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 808.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.47M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 657,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 10.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | -11.10M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061213 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 13.18M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008732 |
| us-gaap | Assets | Assets | USD | 200.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 200.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 185.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 74,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 93.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value | USD | 91.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 93.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 93.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277815 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 702,000 | 2022-01-01 | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-08 | 0000950170-23-018869 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 97.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 657.92M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-08 | 0000950170-22-015570 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 191.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 97.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 2.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 36.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 80.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 80.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 80,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -110.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 283.23M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 48.96M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-12-10 | 0001564590-20-056724 | |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | -6.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -6.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -3.71M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022699 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 45,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded | Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 16.16M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123447 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 74,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Security | 21 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | DeferredFederalStateAndLocalTaxExpenseBenefit | Deferred Federal, State and Local, Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -6.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 301.37M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 162.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 14.30M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 56.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 266,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 18.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 23.93M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 162.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 477,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 689,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 312,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.51 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.037 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.222 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.015 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | 0.034 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022226 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0.039 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent | pure | 0.061 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.028 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 5.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 128.04M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | -6.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations | FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations | USD | -6.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 20.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -110.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 112,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 36.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -34.55M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 21,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 2.47M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 144,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 150,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | -6.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 4.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -8.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 4.51M | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061213 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -6.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | 5.82M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -301.37M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -157,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -92,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 6.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | LeaseCost | Lease, Cost | USD | 708,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.031 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 213,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 855,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 855,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 855,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 855,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022226 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 855,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034808 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 209,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277815 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 12,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | Liabilities | Liabilities | USD | 39.78M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 200.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 25.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 452,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 114.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -112.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -110.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 117.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -117.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 485,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 646,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 843,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 213,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 161,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 540,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 340,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 200,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-12-10 | 0001564590-20-056724 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 200,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 85,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-12-10 | 0001564590-20-056724 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 132,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | 23,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -247,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 5.93M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 25.52M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.13M | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001564590-21-056513 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 746,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 120.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 1.94M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022226 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 9.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 317.61M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 1.47M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 214.12M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 234.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 0 | 2022-07-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022699 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 951,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 247,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -110.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 145,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 96.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 198,000 | 2023-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0000950170-24-092914 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 198,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022226 | |
| us-gaap | RestrictedStockValueSharesIssuedNetOfTaxWithholdings | Restricted Stock, Value, Shares Issued Net of Tax Withholdings | USD | -746,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -633.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 351.37M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 2.94M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022226 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 10.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.8 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.917 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.8 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.044 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.006 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.003 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 23.50M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 4.56M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 11.33 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 2.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 57.97 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 611,325 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022699 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 2.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 3.74M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022699 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.2 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 24.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 21.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 6.37 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 17.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 17.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 7.08 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 24.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 21.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 6.37 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.36 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 4.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | State and Local Income Tax Expense (Benefit), Continuing Operations | USD | 45,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 175.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 694,349 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 283.23M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 115,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 317.61M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 117,000 | 2024-07-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277815 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 80,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 7.67M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 11.43M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 | Stock Repurchase Program, Remaining Authorized Repurchase Amount | USD | 11.09M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0000950170-25-105123 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 69.11M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 178.11M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-12-10 | 0001564590-20-056724 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 | |
| us-gaap | TemporaryEquityValueExcludingAdditionalPaidInCapital | Temporary Equity, Par Value | USD | 175.75M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-12-10 | 0001564590-20-056724 | |
| us-gaap | UnbilledReceivablesCurrent | Unbilled Receivables, Current | USD | 5.82M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007672 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | USD | 943,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 5.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 45.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 62,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094159 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 5.43M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005186 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 79.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 21.59M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-30 | 0001564590-21-016724 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 79.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453807 |